The focus of the revised proposal – also backed by South Africa – will continue to be ensuring “equitable, affordable and timely access” fo...

Global Intellectual Property Centre (GIPC) index on intellectual property (IP) standards once again places India at the bottom of 45 countr...

Recently, during the meeting of Sitharaman and US Commerce Secretary Penny Pritzker both the sides discussed IPR related issues.

During a meeting with representatives from another industry chamber FICCI also, Froman said it was in India's interest to have a strong and...

It will keep the government regularly informed about the developments taking place in IPR cases which have an impact upon India's IPR Polic...

During PM Modi’s visit to the US, the two countries committed to set up an annual high-level IP working group as part of the trade policy f...

On September 8, the Minister had announced that the government will come out with a policy on intellectual property rights (IPRs) to make i...

Commerce and Industry Minister Nirmala Sitharama said her ministry will soon have a think-tank that will enable it to handle IPR issues mor...

On April 30, the US has brought out the Special 301 report, an annual review of the global state of IPR protection and enforcement.

The Obama administration had been strongly criticising India's investment climate and IPR laws, especially in the pharmaceutical and solar ...

American pharma sector had alleged that Indian IPR laws discriminate against US companies and violate global norms.

Three major US cos - Boeing, Abbott and Honeywell - have come in support of India's IPR regime, which has come under attack by American pha...

India will not dilute its IPR laws under pressure from pharma multinationals but will seek to continue dialogue with these cos to address t...

Indian Ambassador to US S Jaishankar has suggested that the Indian government should engage with US pharma firms to deliberate on the matte...

According to the company, which lost a patent case for its cancer drug Glivec, India needs to have fast track courts to deal with IPR dispu...

Glenmark said its US subsidiary has received tentative approval from the US health regulator for its generic Zolmitriptan tablets.

MNCs going in for mergers and acquisitions will soon be required to divest some of their patented technologies to a third-party rival .